EKF Diagnostics Holdings plc

Company Snapshot

Founded: 1990
Entity Type: Public
Employees: 303
Region: U.S.
Revenue: $64.1 Millions
Revenue Year: 2024
Headquarter: Cardiff, U.K.
Key Geographics: U.S., Other Americas, Germany, U.K., Ireland, Rest of Europe, Russia, Middle East and Africa, China, Rest of Asia, Oceania
Corporate Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, CF64 2EZ U.K. Tel. +44-0-2920-710570 www.ekfdiagnostics.com

Company Overview

EKF Diagnostics Holdings plc. Improve global healthcare by providing innovative solutions that empower medical professionals and enhance patient outcomes. EKF Diagnostics Holdings plc is an AIM-listed company based in Penarth, near Cardiff, U.K.. The company has manufacturing sites in the U.S. and Germany and partners with a distribution network to sell products in over 120 countries. EKF is seeking new avenues for enhancing outcomes by expanding its global footprint through strategic partnerships, commercialization endeavors, and distribution agreements.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

EKF Diagnostics Holdings plc In Reports

In Vitro Diagnostics: Technologies and Global Markets

BCC Research Report: Dive into the in vitro diagnostics market analysis and estimates the CAGR for In vitro diagnostics technologies for the historical years 2021 and 2022.

In Vitro Diagnostics (IVD) Analyzers: Global Market

BCC Research Market Report says global market for In Vitro Diagnostics analyzers is estimated to increase from $12.9 billion in 2023 to reach $16.3 billion by 2028, at a (CAGR of 4.7%.

Hemoglobin A1c Testing Devices and Kits Market

BCC Research Market Report says global market for hemoglobin A1c testing devices and kits is estimated to increase from $2.1 billion in 2023 to reach $3.2 billion by 2028, at a CAGR of 9.2%.

Company's Business Segments

  • Point-of-care (POC) : The company provides point-of-care (POC) and central laboratory diagnostic solutions. It designs, manufactures, and markets devices and tests for hemoglobin, HbA1c, glucose, and lactate, as well as a range of clinical chemistry reagents and other products. 

Applications/End User Industries

  • Biotechnology
  • Diagnostics
  • Healthcare
  • Medical Practitioners
  • Life Sciences
  • In-Vitro Diagnostics
  • Hematology
  • Therapeutic Enzymes
  • Enzyme Fermentation
  • Diabetes
AI Sentiment